bims-celmim Biomed News
on Cellular and mitochondrial metabolism
Issue of 2026–08–16
sixteen papers selected by
Marc Segarra Mondejar, AINA



  1. Cell Metab. 2026 Aug 04. pii: S1550-4131(26)00192-0. [Epub ahead of print]38(8): 1527-1528
      Metabolic dysfunction is a defining but poorly understood feature of Alzheimer's disease. Du et al. show that a brain-penetrant GLP-1 receptor agonist rewires astrocyte-neuron metabolic coupling through lactate-driven histone lactylation, linking astrocytic glycolysis to neuronal lipid homeostasis and positioning metabolite signaling as a therapeutic axis in neurodegeneration.
    DOI:  https://doi.org/10.1016/j.cmet.2026.05.007
  2. Nat Rev Mol Cell Biol. 2026 Aug 14.
      Mitochondria are essential metabolic and signalling hubs exposed to stress, and mitochondrial damage is highly detrimental to the cell. Mitophagy - the autophagy of mitochondria - is a key mechanism that maintains both mitochondrial integrity and metabolic flexibility. Mitophagy occurs via multiple pathways that either involve activation of PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin-protein ligase Parkin, or are independent of PINK1 and Parkin. Recessive mutations in PINK1 and PKRN (the gene that encodes Parkin) cause early-onset Parkinson's disease and have provided key mechanistic insights into mitophagy. However, emerging findings indicate that mitophagy is also executed by other molecular routes. Despite these molecular advances in mitophagy characterization, the physiological roles of these pathways in mammals and the specific contexts or conditions in which they operate remain poorly defined. This Review summarizes current understanding of PINK1-Parkin-dependent and independent mitophagy pathways, highlighting mechanistic distinctions and coordinated regulation. We also examine physiological and pathological triggers of mitophagy, as well as the expanding therapeutic potential of targeting mitophagy in disease.
    DOI:  https://doi.org/10.1038/s41580-026-01012-9
  3. Cell Rep. 2026 Aug 07. pii: S2211-1247(26)00852-1. [Epub ahead of print]45(8): 117774
      Hepatic daily rhythms are coordinated by feeding and the molecular circadian clock, ensuring metabolic homeostasis. Disrupted feeding schedules promote circadian misalignment and metabolic diseases but the underlying mechanisms remain scarce. Post-translational modifications have emerged as key regulators of circadian metabolic outputs. Here, we show that the mitochondrial enzyme Acyl-CoA synthetase family member 3 (ACSF3) oscillates in phase with different feeding schedules to drive rhythmic lysine-malonylation and coordinate daily hepatic metabolism. Hepatic Acsf3 knockdown drastically affected lysine-malonylation rhythms, decreased fasting glycemia, insulin sensitivity, and AKT phosphorylation, indicative of perturbed glucose homeostasis. Concomitantly, Acsf3 knockdown shifted lipid oxidation from mitochondria to peroxisomes, enhanced lipogenesis and triglyceride synthesis, while increasing diurnal autophagy. Multi-omics profiling uncovered specific lysine-malonylation targets in glycolysis, the tricarboxylic acid (TCA) cycle, fatty-acid oxidation and autophagy. Our findings uncover hepatic ACSF3 as a pivotal molecular nexus that integrates feeding time with dynamic protein lysine-malonylation and orchestrates the diurnal rhythm of liver metabolism.
    Keywords:  ACSF3; CP: metabolism; CP: molecular biology; acyl-CoA synthetase 3; autophagy; circadian rhythms; lipid metabolism; liver metabolism; lysine-malonylation; mitochondria; multi-omics; post-translational modifications
    DOI:  https://doi.org/10.1016/j.celrep.2026.117774
  4. Cell Rep. 2026 Aug 03. pii: S2211-1247(26)00870-3. [Epub ahead of print]45(8): 117792
      Regulation of phospholipid composition is essential for cellular homeostasis. Phosphatidylserine (PS) synthesized in the endoplasmic reticulum (ER) plays critical roles in the plasma membrane and endolysosomal system. Although aberrant PS metabolism is linked to diseases, its cellular effects remain poorly understood. Here, we reveal a conserved role for PS in maintaining Ca2+ homeostasis. PS deficiency in Drosophila leads to mitochondrial damage, which is reversed by reducing inositol 1,4,5-trisphosphate receptor (IP3R)-mediated ER Ca2+ release. Notably, in mammalian cells with pathological PS levels-either deficiency or excess as in Lenz-Majewski syndrome-IP3R activation leads to oscillatory or reduced ER-surface Ca2+ release, contrasting with steady-state conditions. Manipulating phospholipid composition via the phosphatidylethanolamine (PE)-SREBP axis in Drosophila and the phosphatidylcholine (PC)-SREBP axis in mammals normalizes IP3R-mediated Ca2+ release during PS deficiency. These findings establish modulated ER Ca2+ release as a key function of PS and suggest therapeutic strategies for treating lipid metabolic disorders.
    Keywords:  CP: cell biology; CP: metabolism; Ca(2+); ER; IP(3)R; mitochondrion; phosphatidylserine
    DOI:  https://doi.org/10.1016/j.celrep.2026.117792
  5. Cell Rep. 2026 Aug 14. pii: S2211-1247(26)00935-6. [Epub ahead of print]45(8): 117857
      Tim23 is an essential component of the mitochondrial inner membrane translocase and Sfc1 is a carrier that exchanges succinate for fumarate across that membrane. Sfc1 and succinic acid availability regulate dual targeting of fumarase and aconitase by facilitating mitochondrial import of their newly synthesized precursors, as shown by pulse-chase experiments. Here, we show that Sfc1 associates with Tim23 in vivo, and succinate modulates this association, which in turn affects mitochondrial protein import. Physical interaction between Tim23 and Sfc1 was proven by co-immunoprecipitation, bimolecular fluorescence complementation (BiFC) and biotin-based proximity labeling (TurboID). Proximity labeling and structural modeling-informed mutagenesis allowed us to dissect the carrier activity of Sfc1 from its function as a TIM23 regulator. We performed Rosetta-MP docking of Sfc1 and Tim23 to envisage the interface. Thus, our findings show that metabolites can regulate mitochondrial import and adjust the segregation of key metabolic enzymes between the cytosol and mitochondria.
    Keywords:  CP: cell biology; CP: metabolism; Tim23; aconitase; dual targeting; fumarase; glyoxylate shunt; metabolic signaling; metabolites; mitochondrial protein import; succinate-fumarate carrier; tricarboxylic acid cycle
    DOI:  https://doi.org/10.1016/j.celrep.2026.117857
  6. Cell Metab. 2026 Aug 04. pii: S1550-4131(26)00237-8. [Epub ahead of print]38(8): 1521-1523
      Colorectal cancer (CRC) cells accumulate iron to fuel proliferation yet paradoxically resist its toxicity. Jain et al. reveal that heme stabilizes succinate dehydrogenase subunit C, sustaining complex II-dependent coenzyme Q reduction and its redistribution to the plasma membrane, enabling CRC cells to buffer oxidative stress and iron-induced cell death.
    DOI:  https://doi.org/10.1016/j.cmet.2026.06.011
  7. Dev Cell. 2026 Aug 12. pii: S1534-5807(26)00277-7. [Epub ahead of print]61(8): 1593-1594
      Autophagy is commonly viewed as a cell-autonomous degradative process governed by intracellular metabolic and stress signals,1 but how autophagy is coordinated across tissues in multicellular organisms remains unclear. Zheng et al. 2 identify two parallel neuronal circuits that non-cell-autonomously regulate muscle autophagy in C. elegans, revealing an unexpected role for the nervous system in orchestrating peripheral autophagy.
    DOI:  https://doi.org/10.1016/j.devcel.2026.07.008
  8. Nat Cell Biol. 2026 Aug;28(8): 1612-1625
      Organelle membrane contact sites (MCSs) coordinate key cell activities and their alterations are associated with several high-incidence disorders, prompting an increasing interest in their study. However, the investigation of MCSs is challenging, mostly because of their nanometric size and dynamic nature. Here we highlight the methods that are available for analysing MCSs. We focus on advanced imaging techniques and discuss their advantages and limitations, providing practical guidance for researchers approaching this field. We propose to study MCSs through a combination of different methodologies, complementing their visualization with investigation of the associated functions. To this end, we also discuss the need to develop innovative biosensors.
    DOI:  https://doi.org/10.1038/s41556-026-02003-w
  9. Cell. 2026 Aug 14. pii: S0092-8674(26)00872-X. [Epub ahead of print]
      Polyamines are essential and evolutionarily conserved metabolites present at millimolar concentrations in mammalian cells. Cells tightly regulate polyamine homeostasis through complex feedback mechanisms, yet the precise role necessitating this regulation remains unclear. Here, we show that polyamines contribute to endogenous buffering of redox-active iron, providing a molecular link between polyamine metabolism and ferroptosis. Using a genome-wide CRISPR screen, we identified a synthetic lethal dependency between polyamine depletion and the key ferroptosis suppressor, glutathione peroxidase 4 (GPX4). Mechanistically, we show that polyamine deficiency triggers a redistribution of cellular iron, increasing the labile iron pool and upregulating ferritin. To directly visualize this iron buffering in living cells, we developed a genetically encoded fluorescent reporter for redox-active iron. Live-cell analysis revealed a striking inverse correlation between intracellular polyamine levels and redox-active iron at single-cell resolution. These findings reposition polyamines as key regulators of iron homeostasis, with implications for ferroptosis-linked disease states and cellular redox balance.
    Keywords:  GPX4; ferroptosis; genetically encoded iron sensor; iron homeostasis; labile iron pool; polyamines; redox-active iron; spermidine; spermine
    DOI:  https://doi.org/10.1016/j.cell.2026.07.040
  10. Science. 2026 Aug 13. 393(6812): 651
      Study of mitochondria suggests new treatment strategy for Alzheimer's and other diseases.
    DOI:  https://doi.org/10.1126/science.ael4194
  11. Immunity. 2026 Aug 11. pii: S1074-7613(26)00315-8. [Epub ahead of print]59(8): 2055-2057
      Genetic associations point to a connection between lysosomal function and neurodegeneration. In this issue of Immunity, Balak et al. and Tejwani et al. show that genetically distinct lysosomal insults converge on a shared MITF/TFE-driven epigenetic program that underlies disease-associated microglial states, thereby connecting lysosomal dysfunction with transcriptional regulation in microglia.
    DOI:  https://doi.org/10.1016/j.immuni.2026.07.016
  12. J Vis Exp. 2026 Jul 24.
      We present a reproducible workflow for real-time visualization of nicotinamide adenine dinucleotide (NAD+) biosensor-channel responses in brain microvascular endothelial cells in living mice using cranial-window two-photon microscopy and an endothelial-targeted fluorescent NAD+ sensor. The protocol includes (1) adeno-associated virus (AAV)-mediated expression of the NAD+ sensor selectively in cerebrovascular endothelium using AAV-X1.1 under the Cdh5 promoter (vascular endothelial cadherin), (2) surgical preparation of a stable 3 mm × 3 mm cortical cranial window, and (3) dual-wavelength two-photon imaging to simultaneously capture the 920 nm-excited green sensor-channel signal and the 1040 nm-excited intravascular tetramethylrhodamine (TMR)-dextran reference channel. The TMR-dextran channel provides a vascular lumen reference and supports vessel selection, motion assessment, and vascular-integrity evaluation. As an application example, we describe nicotinamide mononucleotide-associated changes in endothelial sensor-channel fluorescence following drinking-water, oral-gavage, or intravenous delivery. This protocol emphasizes critical steps, recommended viral-dosing and titer considerations, troubleshooting, and quantitative-analysis strategies, enabling laboratories to implement in vivo monitoring of cerebrovascular NAD+ biosensor-channel dynamics for studies of neurometabolism in health and disease.
    DOI:  https://doi.org/10.3791/71358
  13. PLoS Pathog. 2026 Aug 12. 22(8): e1014496
      Lipidome remodeling during human cytomegalovirus (HCMV) replication is a complex process that requires induction of lipogenic proteins and altered metabolite flow to support synthesis of fatty acids and lipids. HCMV infection increases the utilization of glucose and acetate to provide enough carbons to support increased demand for lipogenesis during virus replication, but other carbon contributors have not been studied. Here, we identify glutamine as a carbon source for lipogenesis during HCMV infection. Metabolic tracing with 13C-labeled glutamine revealed carbons from glutamine are enriched in phospholipids and neutral lipids during infection, including phosphatidylcholine, phosphatidylethanolamine, diacylglycerol, and triacylglycerol. Additional metabolic tracing demonstrates that HCMV infection promotes glutamine flow to fatty acid synthesis primarily through reductive carboxylation, i.e., conversion of glutamine to citrate through isocitrate. Through the use of two different 13C-labeled forms of glutamine, we found that ~70% of the carbons from glutamine are delivered to fatty acid synthesis through reductive carboxylation. Our current understanding of metabolite utilization during virus replication is based on cell culture models in which glucose is in excess, suggesting that HCMV may encode mechanisms to promote glutamine flow to lipids if glucose levels in vivo are insufficient. To determine if concentrations of glucose and glutamine change their contributions to fatty acid synthesis, we investigated lipogenesis when glucose and glutamine are at physiological levels (5 mM and 0.55 mM, respectively). We determined that physiological levels of glucose and glutamine are sufficient to support the increased demand for fatty acid synthesis caused by HCMV infection, despite a reduction in virus production. Using metabolic tracing with 13C-labeled forms of glucose or glutamine, we determined that both carbon sources contribute to fatty acid synthesis when present at physiological levels. Overall, our results identify viral activation of reductive carboxylation that increases glutamine flow to lipogenesis during infection. This work provides additional insight into metabolic reprogramming that supports HCMV-induced lipidome remodeling.
    DOI:  https://doi.org/10.1371/journal.ppat.1014496
  14. J Biol Chem. 2026 Aug 10. pii: S0021-9258(26)02302-1. [Epub ahead of print] 113430
      Autophagy is a critical mechanism of cellular quality control, orchestrated by selective autophagy receptor (SAR) proteins. Pharmacologically enhancing the cargo-targeting capacity of SARs presents an attractive but underexplored strategy for the precise therapeutic activation of autophagy. Here, we characterise SQ-1, a small-molecule activator of autophagy that engages the prototypical SAR protein p62/SQSTM1 (sequestosome-1). We show that SQ-1 sensitises p62 to oxidation and promotes its disulphide-mediated oligomerisation in response to mitochondrial reactive oxygen species (ROS). This ROS-dependent activation of p62-mediated selective autophagy enhances the clearance of ROS-generating mitochondria and restores cell viability in models of Niemann-Pick type C1 (NPC1) disease, which is marked by impaired autophagic flux. In summary, the unique mode of action of SQ-1 enables self-regulated autophagy activation, offering a potential therapeutic strategy for lysosomal storage disorders and a broader spectrum of age-related diseases characterised by defective autophagy.
    Keywords:  Autophagy; Mitophagy; Niemann-Pick type C1 disease; Oligomerisation; ROS; p62
    DOI:  https://doi.org/10.1016/j.jbc.2026.113430
  15. Cell. 2026 Aug 10. pii: S0092-8674(26)00825-1. [Epub ahead of print]
      Mutations in leucine-rich repeat kinase 2 (LRRK2) are the second most common cause of autosomal-dominant Parkinson's disease (PD), and increased LRRK2 kinase activity is also observed in idiopathic PD, making LRRK2 a major actionable therapeutic target. LRRK2 is a 286-kDa multidomain enzyme containing a Ras-like GTPase (ROC) and a kinase domain. Using cryo-electron microscopy (cryo-EM), biochemical reconstitution, and cell-based assays, we show that the ROC GTPase governs switching between autoinhibited and active states: GTP binding promotes activation, whereas GDP binding enforces autoinhibition. Two common PD-linked mutations, G2019S and R1441C/G/H, activate LRRK2 through distinct structural mechanisms, revealing genotype-specific routes to dysregulation. These findings provide a unified framework for understanding LRRK2 regulation with broad therapeutic implications. Stabilizing the guanosine diphosphate (GDP)-bound state may inhibit LRRK2 by maintaining autoinhibition, whereas promoting the GTP-bound state could be advantageous in specific cellular contexts, such as the lung, where increased LRRK2 kinase activity may play protective or regulatory roles.
    Keywords:  G2019S; GTPase; LRRK2; Parkinson’s disease; R1441C; R1441H; activation; autoinhibition; cryo-EM; kinase
    DOI:  https://doi.org/10.1016/j.cell.2026.07.027
  16. iScience. 2026 Aug 21. 29(8): 116956
      Insulin's regulation of hepatic glucose production and glycogen is critical for postprandial glucose disposal. AKT, a serine-threonine kinase and insulin signaling intermediate, regulates liver glucose metabolism through transcriptional and posttranslational mechanisms. However, current knowledge largely stems from genetic loss-of-function models, precluding observation of AKT's non-transcriptional effects. To measure rapid changes to glucose and glycogen metabolism, isotope tracing using [U-13C]-glucose and [U-14C]-glucose was coupled with the AKT inhibitor MK-2206 in primary rat hepatocytes. MK-2206 treatment decreased AKT phosphorylation and glucose contribution to glucose 6-phosphate and uridine diphosphate glucose within minutes without affecting metabolite pool sizes or protein levels of glucokinase, glucose 6-phosphatase, or phosphoenolpyruvate carboxykinase. MK-2206 also decreased glucose contribution to glycogen, independent of glycogen breakdown or glycogen synthase phosphorylation. These results demonstrate that AKT acutely regulates glucose contribution to glycogen and upstream precursors, suggesting a transcription-independent mechanism that is proximal to glucose 6-phosphate generation for glycogen synthesis.
    Keywords:  glucokinase; gluconeogenesis; glucose 6-phosphate; glucose homeostasis; glycogen; glycolysis
    DOI:  https://doi.org/10.1016/j.isci.2026.116956